We are live on ! Find out more

1,761 hedge funds and large institutions have $119B invested in Merck in 2016 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 713 increasing their positions, 709 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 92 | Existing positions closed: 59

30% more funds holding in top 10

Funds holding in top 10: 106138 (+32)

11% more capital invested

Capital invested by funds: $107B → $119B (+$11.6B)

1% more funds holding

Funds holding: 1,7441,761 (+17)

1% more repeat investments, than reductions

Existing positions increased: 713 | Existing positions reduced: 709

0.6% less ownership

Funds ownership: 78.67%78.07% (-0.6%)

14% less call options, than puts

Call options by funds: $1.02B | Put options by funds: $1.18B

Holders
1,761
Holders Change
+17
Holders Change %
+0.97%
% of All Funds
46.99%
Holding in Top 10
138
Holding in Top 10 Change
+32
Holding in Top 10 Change %
+30.19%
% of All Funds
3.68%
New
92
Increased
713
Reduced
709
Closed
59
Calls
$1.02B
Puts
$1.18B
Net Calls
-$163M
Net Calls Change
-$87M
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
151
Comerica Bank
Texas
$90.7M -$2.32M -43,627 -3%
HighTower Advisors
152
HighTower Advisors
Illinois
$90.5M -$5.4M -101,419 -6%
EAM
153
Edge Asset Management
Washington
$89.6M +$912K +17,136 +1%
AG
154
Aperio Group
California
$88.7M +$11.5M +216,747 +16%
EAM
155
Eagle Asset Management
Florida
$88.7M +$3.64M +68,375 +4%
National Pension Service
156
National Pension Service
South Korea
$88.5M +$8.2M +154,008 +11%
AAM
157
Aberdeen Asset Management
United Kingdom
$88.2M -$1.44M -27,073 -2%
JHIU
158
Janus Henderson Investors US
Colorado
$87.9M -$18.8M -353,270 -18%
AACR
159
ACR Alpine Capital Research
Missouri
$87.7M -$2.98M -56,061 -3%
SCM
160
Sterling Capital Management
North Carolina
$87.6M -$223K -4,199 -0.3%
Neuberger Berman Group
161
Neuberger Berman Group
New York
$85.9M +$211K +3,957 +0.3%
NMIMC
162
Northwestern Mutual Investment Management Company
Wisconsin
$84.3M +$9.47M +177,861 +13%
CCM
163
Cullen Capital Management
New York
$83.8M +$21.4K +403 +0%
Luther King Capital Management (LKCM)
164
Luther King Capital Management (LKCM)
Texas
$83.7M -$537K -10,090 -0.7%
MLICM
165
Metropolitan Life Insurance Company (MetLife)
New York
$83.2M -$1.92M -36,095 -2%
SCM
166
Smead Capital Management
Arizona
$82.3M -$4.88M -91,755 -6%
Pzena Investment Management
167
Pzena Investment Management
New York
$81.5M +$27.6M +517,738 +54%
BTS
168
BB&T Securities
Virginia
$80.1M -$1.94M -36,524 -2%
State of Tennessee, Department of Treasury
169
State of Tennessee, Department of Treasury
Tennessee
$79.3M +$27.2M +510,705 +55%
CB
170
Commerce Bank
Missouri
$79.2M +$1.68M +31,651 +2%
GC
171
Guggenheim Capital
Illinois
$78.2M -$13.8M -258,915 -15%
SC
172
SRB Corp
Massachusetts
$77.3M
Lazard Asset Management
173
Lazard Asset Management
New York
$77.2M -$19.1M -358,565 -20%
Calamos Advisors
174
Calamos Advisors
Illinois
$74.6M -$19.6M -367,520 -21%
ELC
175
Edgar Lomax Company
Virginia
$73.9M +$3.58M +67,236 +5%

MRK Hedge Fund Activity: Q2 2016 in Review

1,761 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q2 2016, worth a combined $119B — up 11% from $107B a quarter earlier.

Buyers outnumbered sellers: 92 funds opened new MRK positions and 59 closed out — a net gain of 33 holders — while 713 added to existing stakes and 709 trimmed.

The largest buyer was Macquarie Group, adding an estimated $718M. The largest seller was Royal London Asset Management, cutting an estimated $1.98B.

  • 1,761 institutional investors held Merck (MRK) as of Q2 2016, up from 1,744 in Q1 2016.
  • Funds reported $119B of Merck stock for Q2 2016, up 11% quarter-over-quarter.
  • 92 funds opened new Merck positions in Q2 2016 and 59 closed out, a net change of +33 holders.
  • The largest Merck buyer in Q2 2016 was Macquarie Group, an estimated $718M added.
  • The largest Merck seller in Q2 2016 was Royal London Asset Management, an estimated $1.98B sold.

Based on aggregated 13F filings for Q2 2016.